Cargando…
Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools
Plasma membrane monoamine transporter (PMAT, Slc29a4) transports monoamine neurotransmitters, including dopamine and serotonin, faster than more studied monoamine transporters, e.g., dopamine transporter (DAT), or serotonin transporter (SERT), but with ~400–600-fold less affinity. A considerable cha...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220966/ https://www.ncbi.nlm.nih.gov/pubmed/35741002 http://dx.doi.org/10.3390/cells11121874 |
_version_ | 1784732505236045824 |
---|---|
author | Beaver, Jasmin N. Weber, Brady L. Ford, Matthew T. Anello, Anna E. Kassis, Sarah K. Gilman, T. Lee |
author_facet | Beaver, Jasmin N. Weber, Brady L. Ford, Matthew T. Anello, Anna E. Kassis, Sarah K. Gilman, T. Lee |
author_sort | Beaver, Jasmin N. |
collection | PubMed |
description | Plasma membrane monoamine transporter (PMAT, Slc29a4) transports monoamine neurotransmitters, including dopamine and serotonin, faster than more studied monoamine transporters, e.g., dopamine transporter (DAT), or serotonin transporter (SERT), but with ~400–600-fold less affinity. A considerable challenge in understanding PMAT’s monoamine clearance contributions is that no current drugs selectively inhibit PMAT. To advance knowledge about PMAT’s monoamine uptake role, and to circumvent this present challenge, we investigated how drugs that selectively block DAT/SERT influence behavioral readouts in PMAT wildtype, heterozygote, and knockout mice of both sexes. Drugs typically used as antidepressants (escitalopram, bupropion) were administered acutely for readouts in tail suspension and locomotor tests. Drugs with psychostimulant properties (cocaine, D-amphetamine) were administered repeatedly to assess initial locomotor responses plus psychostimulant-induced locomotor sensitization. Though we hypothesized that PMAT-deficient mice would exhibit augmented responses to antidepressant and psychostimulant drugs due to constitutively attenuated monoamine uptake, we instead observed sex-selective responses to antidepressant drugs in opposing directions, and subtle sex-specific reductions in psychostimulant-induced locomotor sensitization. These results suggest that PMAT functions differently across sexes, and support hypotheses that PMAT’s monoamine clearance contribution emerges when frontline transporters (e.g., DAT, SERT) are absent, saturated, and/or blocked. Thus, known human polymorphisms that reduce PMAT function could be worth investigating as contributors to varied antidepressant and psychostimulant responses. |
format | Online Article Text |
id | pubmed-9220966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92209662022-06-24 Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools Beaver, Jasmin N. Weber, Brady L. Ford, Matthew T. Anello, Anna E. Kassis, Sarah K. Gilman, T. Lee Cells Article Plasma membrane monoamine transporter (PMAT, Slc29a4) transports monoamine neurotransmitters, including dopamine and serotonin, faster than more studied monoamine transporters, e.g., dopamine transporter (DAT), or serotonin transporter (SERT), but with ~400–600-fold less affinity. A considerable challenge in understanding PMAT’s monoamine clearance contributions is that no current drugs selectively inhibit PMAT. To advance knowledge about PMAT’s monoamine uptake role, and to circumvent this present challenge, we investigated how drugs that selectively block DAT/SERT influence behavioral readouts in PMAT wildtype, heterozygote, and knockout mice of both sexes. Drugs typically used as antidepressants (escitalopram, bupropion) were administered acutely for readouts in tail suspension and locomotor tests. Drugs with psychostimulant properties (cocaine, D-amphetamine) were administered repeatedly to assess initial locomotor responses plus psychostimulant-induced locomotor sensitization. Though we hypothesized that PMAT-deficient mice would exhibit augmented responses to antidepressant and psychostimulant drugs due to constitutively attenuated monoamine uptake, we instead observed sex-selective responses to antidepressant drugs in opposing directions, and subtle sex-specific reductions in psychostimulant-induced locomotor sensitization. These results suggest that PMAT functions differently across sexes, and support hypotheses that PMAT’s monoamine clearance contribution emerges when frontline transporters (e.g., DAT, SERT) are absent, saturated, and/or blocked. Thus, known human polymorphisms that reduce PMAT function could be worth investigating as contributors to varied antidepressant and psychostimulant responses. MDPI 2022-06-09 /pmc/articles/PMC9220966/ /pubmed/35741002 http://dx.doi.org/10.3390/cells11121874 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Beaver, Jasmin N. Weber, Brady L. Ford, Matthew T. Anello, Anna E. Kassis, Sarah K. Gilman, T. Lee Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools |
title | Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools |
title_full | Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools |
title_fullStr | Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools |
title_full_unstemmed | Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools |
title_short | Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools |
title_sort | uncovering functional contributions of pmat (slc29a4) to monoamine clearance using pharmacobehavioral tools |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220966/ https://www.ncbi.nlm.nih.gov/pubmed/35741002 http://dx.doi.org/10.3390/cells11121874 |
work_keys_str_mv | AT beaverjasminn uncoveringfunctionalcontributionsofpmatslc29a4tomonoamineclearanceusingpharmacobehavioraltools AT weberbradyl uncoveringfunctionalcontributionsofpmatslc29a4tomonoamineclearanceusingpharmacobehavioraltools AT fordmatthewt uncoveringfunctionalcontributionsofpmatslc29a4tomonoamineclearanceusingpharmacobehavioraltools AT anelloannae uncoveringfunctionalcontributionsofpmatslc29a4tomonoamineclearanceusingpharmacobehavioraltools AT kassissarahk uncoveringfunctionalcontributionsofpmatslc29a4tomonoamineclearanceusingpharmacobehavioraltools AT gilmantlee uncoveringfunctionalcontributionsofpmatslc29a4tomonoamineclearanceusingpharmacobehavioraltools |